Compare W & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | W | CRL |
|---|---|---|
| Founded | 2002 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 10.8B |
| IPO Year | 2014 | 1999 |
| Metric | W | CRL |
|---|---|---|
| Price | $101.64 | $277.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 12 |
| Target Price | $105.82 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 3.7M | 883.5K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.15 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | $7.39 | N/A |
| Revenue Next Year | $6.00 | $3.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $55.60 | $144.26 |
| 52 Week High | $119.98 | $288.02 |
| Indicator | W | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 58.19 | 76.29 |
| Support Level | $94.54 | $153.47 |
| Resistance Level | $116.97 | N/A |
| Average True Range (ATR) | 5.19 | 9.15 |
| MACD | 0.32 | 3.32 |
| Stochastic Oscillator | 56.70 | 86.97 |
Wayfair engages in e-commerce in the United States (88% of 2025 sales), Canada, the United Kingdom, and Ireland. It's also embarked on expansion into the brick-and-mortar landscape, with 13 stores (excluding outlets) between the AllModern, Birch Lane, Joss & Main, and Wayfair banners. At the end of 2025, the firm offered more than 40 million products from more than 20,000 suppliers under the brands Wayfair, Joss & Main, AllModern, Birch Lane, and Perigold. Its offerings include furniture, everyday and seasonal decor, decorative accents, housewares, as well as advertising and logistics services. Wayfair was founded in 2002 and began trading publicly in 2014.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.